Free Trial

Candel Therapeutics (CADL) Insider Trading & Ownership

Candel Therapeutics logo
$4.62 -0.22 (-4.55%)
(As of 05:00 PM ET)

Candel Therapeutics (NASDAQ:CADL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
41.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$753,016.01
Get CADL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CADL Insider Buying and Selling by Quarter

Candel Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/14/2024Estuardo Aguilar-CordovaMajor ShareholderSell15,000$6.02$90,300.00  
10/11/2024Estuardo Aguilar-CordovaMajor ShareholderSell15,000$6.05$90,750.00  
10/3/2024Estuardo Aguilar-CordovaMajor ShareholderSell1,800$6.85$12,330.00  
7/17/2024Charles SchochInsiderSell9,884$6.47$63,949.48  
7/17/2024Paul Peter TakCEOSell22,528$6.47$145,756.16  
7/17/2024Seshu TyagarajanCTOSell14,851$6.47$96,085.97  
7/11/2024Charles SchochInsiderSell8,897$5.97$53,115.09  
7/11/2024Paul Peter TakCEOSell20,293$5.97$121,149.21  
7/11/2024Seshu TyagarajanCTOSell13,330$5.97$79,580.10  
(Data available from 1/1/2013 forward)

CADL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Candel Therapeutics includes Charles Schoch, Estuardo Aguilar-Cordova, Francesca Barone, Jason Amello, Joseph C Papa, Paul Peter Tak, and Seshu Tyagarajan. Learn more on insiders at CADL.

41.60% of Candel Therapeutics stock is owned by insiders. Learn more on CADL's insider holdings.

The following insiders have purchased CADL shares in the last 24 months: Francesca Barone ($1,993.18), Jason Amello ($5,239.00), Joseph C Papa ($5,123.80), Paul Peter Tak ($5,185.00), and Seshu Tyagarajan ($5,070.00).

Insiders have purchased a total of 13,402 CADL shares in the last 24 months for a total of $22,610.98 bought.

The following insiders have sold CADL shares in the last 24 months: Charles Schoch ($117,064.57), Estuardo Aguilar-Cordova ($193,380.00), Paul Peter Tak ($266,905.37), and Seshu Tyagarajan ($175,666.07).

Insiders have sold a total of 121,583 Candel Therapeutics shares in the last 24 months for a total of $753,016.01 sold.

Candel Therapeutics Key Executives

  • Dr. Paul-Peter Tak FMEDSCI (Age 63)
    M.D., Ph.D., President, CEO & Director
    Compensation: $1.12M
  • Dr. Estuardo Aguilar-Cordova Inf. (Age 65)
    M.D., Ph.D., Founder & Director
    Compensation: $35k
    3 recent trades
  • Dr. Francesca Barone M.D. (Age 46)
    Ph.D., Chief Scientific Officer
    Compensation: $506.76k
  • Mr. Charles Schoch (Age 39)
    Interim CFO, VP of Finance & Corporate Controller
    2 recent trades
  • Dr. Seshu Tyagarajan Ph.D. (Age 56)
    Chief Technical & Development Officer
    Compensation: $335.27k
  • Ms. Ileen B. Winick
    Chief People Officer
  • Ms. Susan Stewart J.D. (Age 63)
    L.L.M., Chief Regulatory Officer
  • Dr. William Garrett Nichols M.D. (Age 55)
    M.S., Chief Medical Officer


This page (NASDAQ:CADL) was last updated on 11/26/2024 by MarketBeat.com Staff
From Our Partners